Myriad Genetics, Inc. (MYGN) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Myriad Genetics, Inc. (MYGN) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $352.3M, listed on NASDAQ, employing roughly 2,700 people, carrying a beta of 1.64 to the broader market. Myriad Genetics, Inc. Led by Samraat S. Raha, public since 1995-10-06.
Snapshot as of May 15, 2026.
- Spot Price
- $3.59
- Total OI
- 2.2K